Funding · Company
ALZHEON, INC.
Framingham, MABiotech & Pharma
ALZHEON, INC. of Framingham, MA has disclosed $126M across 1 Form D offering filed with the SEC on Feb 10, 2025.
$126M
Total disclosed
1
Form D offering
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$126M
Form D · Feb 10, 2025 ↗
Q1 2025
· 2 amendments, first filed Mar 12, 2024
· target $150M
Filing details
HeadquartersFramingham, MAIndustryBiotech & Pharma (Biotechnology)SEC CIK0001582636Offerings on file1
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →